MC10: MC10s BioStamp nPoint to be used in Neurocrine BiosciencesÂstudy of Huntington disease

Wearable medical devices provider MC10 announced that its BioStamp nPoint system will be used in a Phase III clinical study to collect and assess movement activity data. The The post MC10s BioStamp nPoint to be used in Neurocrine BiosciencesÂstudy of Hunti...